Advertisement

Topics

Dabigatran superior to warfarin when anticoagulation is resumed after bleeding

19:00 EST 30 Nov 2016 | AAAS

(University of Pittsburgh Schools of the Health Sciences) In the first analysis of how to treat patients on anticoagulants who suffer a major bleeding event, a clinical practice that routinely gives doctors pause, while also evaluating a new drug, University of Pittsburgh researchers aim to provide much-needed guidance to clinicians trying to balance the risks of stroke versus bleeding when determining the best treatment.

Original Article: Dabigatran superior to warfarin when anticoagulation is resumed after bleeding

NEXT ARTICLE

More From BioPortfolio on "Dabigatran superior to warfarin when anticoagulation is resumed after bleeding"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...